Published October 2000 | Version v1
Journal article

Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany

  • 1. Inst. of Medical Informatics, Justus-Liebig-Univ. Giessen (Germany)
  • 2. Clinic for Nuclear Medicine, Justus-Liebig-Univ. Giessen (Germany)
  • 3. Clinic and Policlinic for Nuclear Medicine, Univ. of Wuerzburg (Germany)
  • 4. Commission on Cancer, American Coll. of Surgeons, Chicago (United States)

Description

This prospective, observational study of a cohort of thyroid cancer patients in Germany focusses on the ''real-world'' practice in the management of thyroid cancer patients. This report includes data from 2376 patients with primary differentiated thyroid carcinoma first diagnosed in the year 1996. The study reveals considerable differences in actual practice concerning surgery and radioiodine treatment. The results indicate that consensus is lacking with respect to the multimodality treatment approach for differentiated thyroid carcinoma. Our analysis represents the most current and comprehensive national assessment of presenting patient characteristics, diagnostic tests, treatment and complications for thyroid cancer. (orig.)

Additional details

Publishing Information

Journal Title
European Journal of Nuclear Medicine
Journal Volume
27
Journal Issue
10
Journal Page Range
p. 1465-1472
ISSN
0340-6997
CODEN
EJNMD9